Spravato Treatment: What Patients Should Know

Depression treatment is not always straightforward.

For many people, antidepressant medication, psychotherapy, lifestyle changes, or a combination of approaches can provide meaningful improvement. But some people continue experiencing significant depressive symptoms despite trying treatment.

When depression persists after appropriate treatment attempts, healthcare providers may begin discussing additional options.

One of those options is Spravato treatment.

Spravato is the brand name for esketamine, a prescription nasal spray used under specific medical circumstances for certain adults with depression. Unlike a medication that a patient simply picks up and takes home independently, Spravato is administered under medical supervision with monitoring afterward.

Patients often discover Spravato while researching ketamine and understandably have questions.

Is Spravato ketamine? How does the nasal spray work? Who can receive it? What happens during an appointment? How long do you stay at the clinic? And how is it different from IV ketamine therapy?

Understanding these differences can make discussions with your healthcare provider much more productive.

What Is Spravato?

Spravato is the brand name for esketamine, a prescription medication administered as a nasal spray.

Esketamine is chemically related to ketamine, but Spravato and IV ketamine treatment should not be treated as interchangeable terms.

Spravato has specific FDA-approved indications and requirements governing how it is administered.

Unlike many medications taken independently at home, Spravato must be administered in a certified healthcare setting under appropriate supervision.

Patients are monitored following administration before leaving the treatment center.

That supervised structure is an important part of Spravato treatment.

What Is Esketamine?

Ketamine consists of two mirror-image molecular forms, known as enantiomers.

Esketamine is the S-enantiomer of ketamine.

That relationship explains why discussions about Spravato frequently overlap with conversations about ketamine therapy.

However, the treatments differ in several important ways, including formulation, route of administration, regulatory status, treatment protocols, and clinical use.

Spravato is administered intranasally.

IV ketamine is administered intravenously.

Patients should therefore avoid assuming that information about one automatically applies to the other.

What Is Treatment-Resistant Depression?

One of the most important terms patients encounter while researching Spravato is treatment-resistant depression, often abbreviated as TRD.

Treatment-resistant depression generally refers to depression that has not responded adequately to appropriate previous antidepressant treatment.

This does not mean someone has simply felt depressed for a long time.

Determining whether depression is treatment-resistant requires consideration of previous treatments, how they were used, and how the patient responded.

A healthcare professional needs to review this history rather than relying on self-diagnosis.

For people who continue experiencing significant symptoms despite previous treatment, discussing additional options can be an important next step.

How Is Spravato Different From Traditional Antidepressants?

Many commonly used antidepressants influence neurotransmitter systems involving serotonin, norepinephrine, or dopamine.

Esketamine works differently.

Its mechanism involves the brain’s glutamate system, including activity associated with NMDA receptors.

Glutamate is an important neurotransmitter involved in communication between nerve cells.

This different mechanism is one reason treatments involving ketamine and esketamine have attracted significant interest in psychiatry.

However, having a different mechanism does not mean Spravato is automatically superior to conventional antidepressants for every patient.

Treatment decisions depend on the individual’s clinical circumstances.

Is Spravato the Same as IV Ketamine?

No.

Although esketamine and ketamine are related, Spravato treatment and IV ketamine therapy are different treatments.

Spravato

Spravato contains esketamine and is administered as a nasal spray under medical supervision according to its approved treatment requirements.

IV Ketamine

IV ketamine therapy involves administering ketamine intravenously in a clinical setting.

The medications, routes of administration, protocols, and regulatory frameworks differ.

Patients researching both options should discuss those distinctions with a qualified healthcare provider rather than choosing based solely on online comparisons.

Why Is Spravato Given in a Healthcare Setting?

Spravato is not designed to be taken home and used independently.

Treatment takes place in an appropriately certified healthcare setting because patients need observation and monitoring after administration.

Potential effects can include changes in perception, sedation, increases in blood pressure, and other reactions requiring appropriate clinical monitoring.

This is why patients remain at the treatment center after receiving the medication.

The supervised process is a safety requirement, not simply an optional clinic preference.

What Happens During a Spravato Appointment?

Knowing the general process can make the first appointment feel less unfamiliar.

Before Treatment

The healthcare team reviews relevant information and provides instructions regarding preparation.

Patients should disclose:

  • Current medications
  • Medical conditions
  • Mental health history
  • Recent health changes
  • Substance use when relevant
  • Previous treatment experiences

Follow the clinic’s specific instructions regarding food, liquids, medications, and other preparation.

Do not independently stop prescribed medications because you are planning to receive Spravato.

Administration

Spravato is administered intranasally using the medication’s nasal spray device.

The patient self-administers the medication under the supervision of a healthcare professional according to the prescribed dose and treatment protocol.

Monitoring

After administration, the patient remains at the healthcare facility for observation.

The healthcare team monitors the patient and assesses relevant clinical factors.

Patients should immediately communicate anything that feels concerning.

Leaving the Clinic

Patients should not assume they can simply drive themselves home immediately after treatment.

Spravato has specific post-treatment safety requirements.

Your healthcare team will explain transportation and activity restrictions before treatment.

Plan accordingly.

How Long Are Patients Monitored?

Spravato requires patients to remain under observation after administration.

Patients are generally monitored for at least two hours following treatment.

The healthcare provider determines when the patient is clinically ready to leave.

This means a Spravato appointment requires more planning than a quick medication visit.

Patients should account for treatment administration, the observation period, transportation, and post-treatment restrictions when arranging their schedule.

Can You Drive After Spravato Treatment?

Patients should not plan to drive themselves home after Spravato.

Because the medication can cause sedation and other effects that may impair functioning, patients need to follow the transportation and driving instructions provided by their healthcare team.

This is something to arrange before arriving for treatment.

If transportation presents a problem, discuss it with the clinic while scheduling rather than discovering the issue at the end of the appointment.

What Can Spravato Feel Like?

Individual experiences vary.

Some patients may experience temporary changes in perception or awareness.

Others may experience sedation, dizziness, nausea, or other effects.

Because the medication can produce significant short-term effects, clinical monitoring is required.

Patients who are nervous about what treatment may feel like should discuss those concerns before their first session.

Knowing what to expect can reduce some of the uncertainty surrounding a new treatment.

What Is Dissociation?

One term patients may encounter when researching Spravato is dissociation.

Dissociation can involve temporary changes in how someone experiences themselves, their thoughts, time, or their surroundings.

The experience can vary significantly between individuals.

Because Spravato can produce dissociative effects, treatment occurs in a monitored healthcare environment.

If something feels uncomfortable during treatment, communicate with the clinical team.

You are not expected to determine on your own whether an experience is normal.

Why Is Blood Pressure Monitored?

Spravato can cause increases in blood pressure.

For this reason, blood pressure assessment forms part of the treatment and monitoring process.

Your healthcare provider can explain how this applies to you and whether any health conditions require additional consideration.

This also illustrates why providing a complete medical history before treatment is important.

Spravato is not merely a nasal spray that can be evaluated without considering the rest of the patient’s health.

Who May Be Considered for Spravato?

Eligibility is determined through professional clinical evaluation.

Spravato has specific approved uses and should not be treated as a general-purpose treatment for anyone experiencing sadness, stress, or occasional low mood.

A provider may need to consider factors including:

  • Diagnosis
  • Severity of symptoms
  • Previous treatment history
  • Current medications
  • Medical history
  • Psychiatric history
  • Potential contraindications
  • Individual risk factors

A consultation is therefore about determining appropriateness, not simply requesting a particular medication.

Does Spravato Replace Therapy?

Spravato should not be viewed as a replacement for every other component of mental healthcare.

Depression treatment may involve several elements depending on the individual, including:

  • Medication management
  • Psychotherapy
  • Psychiatric care
  • Lifestyle support
  • Social support
  • Other clinically appropriate treatments

Patients should discuss their existing care with the provider evaluating them for Spravato.

The objective is coordinated treatment.

Should You Stop Your Current Antidepressant?

Do not stop or change prescribed medication simply because you are considering Spravato.

Medication changes should be discussed with the appropriate prescribing healthcare professional.

Abruptly stopping certain psychiatric medications can create problems.

Bring an accurate medication list to your consultation and allow the healthcare team to determine what should continue, change, or be discussed with another treating provider.

How Many Spravato Treatments Are Needed?

Spravato treatment follows a structured dosing schedule determined according to the medication’s prescribing requirements and the patient’s clinical situation.

The frequency can change across different phases of treatment.

Rather than copying a schedule from another patient or an online discussion, follow the treatment plan provided by your healthcare team.

Ask your provider:

  • How frequently treatment will initially occur
  • When the schedule may change
  • How progress will be assessed
  • How long treatment may continue
  • What happens if there is inadequate improvement

These questions help patients understand the full commitment before beginning treatment.

How Quickly Does Spravato Work?

People researching treatment-resistant depression understandably want to know how quickly they might feel different.

There is no responsible way to guarantee an individual timeline.

Responses vary.

Some people may notice changes differently or at different points in treatment than others.

The healthcare team should evaluate progress over time rather than promising that a specific patient will feel better after a specific number of hours or treatments.

Online testimonials can describe individual experiences, but they cannot predict yours.

Is Spravato a Cure for Depression?

No responsible mental health provider should promise that Spravato will permanently cure every patient’s depression.

Depression is complex.

Symptoms, underlying factors, treatment histories, coexisting conditions, and individual responses vary considerably.

Spravato can be an important treatment option for appropriate patients, but expectations should remain realistic.

The goal is to determine whether the treatment contributes meaningfully to an individualized mental healthcare plan.

Spravato and Suicidal Thoughts

This topic requires particular care.

Spravato has specific approved uses involving certain adults with depressive symptoms, but a scheduled outpatient Spravato appointment should never be treated as a substitute for immediate crisis intervention.

If you are experiencing suicidal thoughts, self-harm risk, or an immediate emotional crisis, seek help immediately.

In the United States:

  • Call or text 988 for the Suicide & Crisis Lifeline.
  • Call 911 when there is immediate danger.
  • Go to the nearest emergency department.
  • When possible, stay with or contact a trusted person who can help you obtain immediate support.

Do not wait for a future clinic appointment when immediate safety is at risk.

Why Spravato Requires REMS

Spravato is subject to a Risk Evaluation and Mitigation Strategy, commonly called a REMS program.

REMS programs are used by the FDA for certain medications when specific safety measures are necessary to help ensure that the medication’s benefits outweigh its risks.

For Spravato, this contributes to requirements surrounding certified treatment settings, administration, monitoring, and dispensing.

Patients do not need to become regulatory experts.

The practical takeaway is that Spravato treatment has specific safety procedures that clinics and patients need to follow.

How to Choose a Spravato Clinic

Patients often begin with a search such as “Spravato near me.”

Proximity matters because treatment can involve recurring appointments, but location should not be the only consideration.

Appropriate Certification

Because Spravato has specific administration requirements, treatment needs to occur through an appropriately participating healthcare setting.

Qualified Clinical Team

Understand who evaluates you, who supervises treatment, and who monitors your progress.

Thorough Screening

A clinic should determine whether treatment is appropriate rather than automatically accepting every patient.

Monitoring

Ask what occurs during the required observation period.

Follow-Up

Treatment should include evaluation of your response over time.

Clear Expectations

The clinic should explain what Spravato can potentially offer without guaranteeing a particular outcome.

Spravato Treatment in Lee’s Summit

For patients in the Kansas City metropolitan area, Ascend Wellness Centers provides mental health treatment services through its Lee’s Summit, Missouri location.

This makes Lee’s Summit an accessible option for many patients researching advanced depression treatment in the Kansas City area.

Because Spravato requires repeated in-clinic administration and observation when prescribed, location and transportation can become important practical considerations.

Patients should discuss the treatment schedule and transportation requirements before beginning.

Spravato, Ketamine, and Choosing Between Options

Patients frequently arrive after researching both IV ketamine and Spravato.

The internet often frames the question as:

Which one is better?

That is not necessarily the most useful question.

A better question is:

Which treatment, if either, is clinically appropriate for my circumstances?

Factors may include diagnosis, previous treatment, health history, medication history, provider recommendations, treatment availability, insurance considerations, and individual preferences.

A clinical consultation can help clarify those differences.

Questions to Ask at a Spravato Consultation

Before beginning treatment, consider asking:

Why might Spravato be appropriate for me?

Your provider should explain the clinical reasoning.

What alternatives should I consider?

Understanding options supports informed decision-making.

What should I expect during my first treatment?

Ask about the complete process from arrival through discharge.

How long will I be at the clinic?

Remember to include the monitoring period.

What transportation arrangements do I need?

Plan before treatment day.

What side effects should I know about?

Understand both common concerns and when to seek medical attention.

How will we measure whether treatment is helping?

There should be a plan for evaluating progress.

How does Spravato fit with my existing mental health care?

Discuss medication, therapy, psychiatric treatment, and other ongoing care.

Preparing for Your First Treatment

Follow the specific instructions provided by the Ascend Wellness clinical team.

Do not rely on preparation instructions from blogs, forums, or another clinic because your circumstances may differ.

Make transportation arrangements in advance.

Wear comfortable clothing and plan enough time so you are not rushing immediately before or after treatment.

Bring an accurate medication list and inform the clinical team of any significant changes in your health.

Most importantly, ask questions before treatment begins.

The Importance of Ongoing Monitoring

Spravato is not simply a treatment that is administered repeatedly without reassessment.

Mental health symptoms can change.

Medication needs can change.

Life circumstances can change.

Other treatments may also be occurring simultaneously.

Ongoing monitoring helps the clinical team understand whether the current plan remains appropriate.

Patients should communicate openly about improvements, lack of improvement, new symptoms, side effects, or other concerns.

Don’t Compare Your Progress With Social Media

Online communities can be useful for helping people feel less isolated.

But another patient’s Spravato experience cannot predict yours.

Someone may describe improvement early in treatment.

Another person may experience a different timeline.

Another may not respond as hoped.

Mental healthcare is highly individualized.

Use personal stories as experiences, not as guarantees or treatment instructions.

A More Informed Approach to Depression Treatment

Persistent depression can make people feel as though they have run out of options.

Treatment-resistant does not necessarily mean untreatable.

It means the existing treatment approach may need reassessment.

For some appropriately evaluated adults, Spravato treatment may become one of the options considered.

For others, a provider may recommend a different strategy.

The value of a consultation is understanding those options rather than trying to make the decision alone based on online information.

Finally

Spravato has expanded the treatment options available for certain adults experiencing difficult-to-treat depression.

Its active ingredient, esketamine, works differently from many conventional antidepressants and is administered intranasally under medical supervision.

But Spravato is not an ordinary take-home nasal spray.

Treatment involves clinical evaluation, supervised administration, required monitoring, transportation planning, and ongoing assessment.

Patients considering Spravato should understand both its potential role and its limitations.

At Ascend Wellness Centers, the process begins with determining whether the treatment is appropriate for the individual rather than promising a particular outcome.

If you’ve continued experiencing significant depressive symptoms despite previous treatment, speaking with a qualified healthcare provider can help you understand whether Spravato, IV ketamine, medication management, or another treatment strategy deserves consideration.

Want to Learn Whether Spravato May Be an Option?

If depression continues to significantly affect your life despite previous treatment, the Ascend Wellness team can help you explore available options.

A consultation allows a healthcare provider to review your treatment history, current symptoms, medications, and whether Spravato or another treatment approach may be appropriate.

📍 Lee’s Summit, Missouri – Kansas City Area

Schedule a consultation with Ascend Wellness Centers to discuss your treatment options.

If you’re experiencing an immediate mental health crisis or suicidal thoughts, call or text 988, call 911 if there is immediate danger, or go to the nearest emergency department.

Request a Call Back

Leave your details and our team will contact you during business hours.